SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): June 7, 2013

 

 

USMD Holdings, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-35639   27-2866866

(State of

incorporation)

 

(Commission File

Number)

 

(IRS Employer

Identification Number)

6333 North State Highway, Suite 200

Irving, Texas 75038

(Address of principal executive offices)

Registrant’s telephone number, including area code: (214) 493-4000

Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the reporting obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act

 

¨ Soliciting material pursuant to Rule 14a-12 of the Exchange Act

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) Exchange Act

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) Exchange Act

 

 

 


Item 5.07 Submission of Matters to a Vote of Security Holders

(a) On June 7, 2013, USMD Holdings, Inc. (the “Company”) held its 2013 Annual Meeting of Stockholders (the “Annual Meeting”) at which the Company’s stockholders voted upon four proposals. The proposals are described in detail in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 26, 2013 (the “Proxy Statement”).

(b) A brief description of the proposal and the final results of the votes for each proposal are set forth below. As of the record date for the Annual Meeting, holders of a total of 10,080,511 shares of outstanding common stock were entitled to vote on the proposals.

Proposal 1: The Company’s stockholders elected all eleven director nominees to serve as members of the Company’s board of directors until the Company’s 2014 Annual Meeting of Stockholders or until his or her respective successor has been elected and qualified.

 

Nominee for Director

 

For

 

Withheld

 

Broker Non-Votes

John M. House, M.D.

  8,935,608   20,979   194,336

Steven Brock, M.D.

  8,921,165   35,422   194,336

Darcie Bundy

  8,923,829   32,758   194,336

Breaux Castleman

  8,924,312   32,275   194,336

M. Patrick Collini, M.D.

  8,935,608   20,979   194,336

Charles Cook, M.D.

  8,938,372   18,215   194,336

Russell Dickey, M.D.

  8,921,165   35,422   194,336

Gary Rudin

  8,921,648   34,939   194,336

James Saalfield, M.D.

  8,935,608   20,979   194,336

Paul Thompson, M.D.

  8,921,869   34,718   194,336

Khang Tran, M.D.

  8,921,165   35,422   194,336

Proposal 2: The Company’s stockholders ratified the appointment of Grant Thornton, L.L.P. as the independent auditor of the Company for the fiscal year ending December 31, 2013.

 

For

 

Against

 

Abstain

9,108,006

  23,216   38,673

Proposal 3: The Company’s stockholders approved, through an advisory, non-binding vote, the executive compensation of the Company’s named executive officers as disclosed in the Proxy Statement.

 

For

 

Against

 

Abstain

 

Broker Non-Votes

8,936,602

  14,104   5,881   194,336

Proposal 4: The Company’s stockholders determined, through an advisory, non-binding vote, that the preferred frequency of an advisory vote on the executive compensation of the Company’s named executive officers should be every three years.

 

One Year

 

Two Years

 

Three Years

 

Abstain

 

Broker Non-Votes

44,056

  440   8,891,884   20,207   194,336

(d) In light of the stockholder vote at the Annual Meeting on Proposal 4 as reported above, the Company’s Board of Directors has determined that the Company will include a non-binding, advisory vote in its proxy materials to approve the compensation of its named executive officers as disclosed in such proxy materials every three years year until the next required vote on the frequency of stockholder votes on the compensation of the Company’s named executive officers.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    USMD HOLDINGS, INC.
Date: June 20, 2013     By:   /s/ Greg Cardenas
      Greg Cardenas
      Executive Vice President, Secretary and General Counsel